IP Library Granted Patent US 11,397,189
Granted Patent B2
US 11,397,189 · App. 15/407,876 · Granted Jul 26, 2022

Methods for determining a tumor margin in a tissue using a desorption electrospray ionization (desi) technique

Inventors: Robert Graham Cooks (West Lafayette, IN); Kevin Scott Kerian (Lafayette, IN); Alan Keith Jarmusch (Lafayette, IN); Ahmed Mohamed Hamid (West Lafayette, IN); Livia Schiavinato Eberlin (Lafayette, IN)
Assignee: Purdue Research Foundation
G01N33/92G01N27/62G01N33/50G01N2560/00G01N2800/7028H01J49/0004H01J49/142
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,397,189
App. No.
15/407,876
Granted
Jul 26, 2022
Kind
B2
Abstract

The invention generally relates to methods for analyzing a metabolite level in a sample. In certain embodiments, methods of the invention may involve obtaining a sample, analyzing the sample using a mass spectrometry technique to determine a level of at least one metabolite in the sample, and correlating the metabolite level with an originating source of the sample, thereby analyzing the sample.

Claims (12)

1. A method for determining a tumor margin, the method comprising:

depositing a tissue sample onto a substrate, wherein the tissue sample comprises at least one metabolite indicative of a cancer at one or more locations of the tissue sample;

conducting a desorption electrospray ionization (DESI) technique on the one or more locations of the tissue sample using a solvent selected from the group consisting of: acetonitrile (ACN):ethanol (EtOH) and acetonitrile (ACN):chloroform (CHCl 3 ) that does not destroy native tissue morphology of the tissue sample in order to desorb the at least one metabolite from the one or more locations of the tissue sample and direct the at least one metabolite into a mass spectrometer to thereby generate at least one mass spectral signal of the at least one metabolite from the one or more locations;

performing a histochemistry analysis technique on the tissue sample to stain the tissue sample and produce an optical image of the stained tissue sample;

overlaying spatial molecular information derived from the at least one mass spectral signal onto the optical image of the stained tissue sample to produce an overlaid image; and

defining one or more tumor margins between cancerous and non-cancerous tissue based on the overlaid image.

2. The method according to claim 1 , wherein the DESI technique is performed without prior sample preparation.

3. The method according to claim 1 , wherein the tissue sample is from a frozen tissue sample.

4. The method according to claim 1 , wherein the tissue sample is a human tissue sample.

5. The method according to claim 4 , wherein the human tissue sample is a distribution of cells and extracellular matrix that is spread on the substrate.

6. The method according to claim 1 , wherein the histochemistry analysis technique is Haemotoxylin and Eosin (H&E) staining.

7. The method according to claim 1 , wherein the DESI technique is performed in a negative ion mode.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 22, 2022
From: COOKS, ROBERT GRAHAM; KERIAN, KEVIN SCOTT; JARMUSCH, ALAN KEITH; EBERLIN, LIVIA SCHIAVINATO
To: PURDUE RESEARCH FOUNDATION
Reel/Frame 059342/0020 →
CONFIRMATORY LICENSE Recorded May 22, 2017
From: PURDUE UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 042512/0547 →
Continuity (6)
Continuation 13909619 · Jun 4, 2013
Continuation In Part 13475305 · May 18, 2012
Provisional Application 61487363 · May 18, 2011
Provisional Application 61791100 · Mar 15, 2013
Provisional Application 61778292 · Mar 12, 2013
Related Publication 20170248607A1 · Aug 31, 2017